Your selections:
A cross-sectional analysis of pharmaceutical industry-funded events for health professionals in Australia
- Fabbri, Alice, Grundy, Quinn, Mintzes, Barbara, Swandari, Swestika, Moynihan, Ray, Walkom, Emily, Bero, Lisa A.
A preliminary analysis of the pharmaceutical provisions in the Australia-United States Free Trade Agreement on prescription medicines in Australia
Ascending to new heights for novel therapeutics for eosinophilic esophagitis
- Hirano, Ikuo, Dellon, Evan S., Peterson, Kathryn, Talley, Nicholas J., Bierdermann, Luc, von Arnim, Ulrike, Savarino, Edoardo V., Schlag, Christoph, Wershil, Barry K., Menard-Katcher, Calies, Muir, Amanda B., Wechsler, Joshua B., Falk, Gary W., Chehade, Mirna, Spergel, JM, Atkins, D, Oliva, S, Arva, NC, Guang-Yu, Y, Jensen, ET, Safroneeva, E, Ackerman, S, Gupta, SK, Gonsalves, Nirmala P., Rothenberg, M, Katzka, D, Pletneva, M, Wright, BL, Hiremath, G, Klion, A, Attwood, S, Bonis, P, Aceves, S, Ghisa, M, Furuta, Glenn T., Miehlke, S, Vanuytsel, T, Woodland, G, Thomas, G, Kuang, FL, Bredenoord, Albert J., Assessment of Clinical endpoints in Eosinophilic esophagitis for Novel Therapeutics (ASCENT) working group,, Straumann, Alex, Schoepfer, Alain, Chang, Joy W.
Boards of directors and organizational ambidexterity in knowledge-intensive firms
- Oehmichen, Jana, Heyden, Mariano L. M., Georgakakis, Dimitrios, Volberda, Henk W.
Can pharmacoeconomic guidelines be implemented successfully in Asia? (editorial)
- Kerridge, I., Maguire, Jane, Newby, David A., McNeill, P. M., Henry, David, Hill, Suzanne, Day, R., Macdonald, G., Stokes, Barrie J., Henderson, Kim M.
Country, sex, EDSS change and therapy choice independently predict treatment discontinuation in multiple sclerosis and clinically isolated syndrome
- Meyniel, Claire, Spelman, Timothy, Grammond, Pierre, Iuliano, Gerardo, Fiol, Marcela, Cabrera-Gomez, Jose Antonio, Fernandez-Bolanos, Ricardo, Giuliani, Giorgio, Lechner-Scott, Jeannette, Cristiano, Edgardo, Herbert, Joseph, Petkovska-Boskova, Tatjana, Jokubaitis, Vilija G., Trojano, Maria, Izquierdo, Guillermo, Grand’Maison, François, Oreja-Guevara, Celia, Boz, Cavit, Lugaresi, Alessandra, Girard, Marc
Disease mongering is now part of the global health debate
- Moynihan, Ray, Doran, Evan, Henry, David
Doctors and drug companies: is the dangerous liaison drawing to an end?
Geographical variations in sex ratio trends over time in multiple sclerosis
- Trojano, Maria, Lucchese, Guglielmo, Bergamaschi, Roberto, Giuliani, Giorgio, Boz, Cavit, Hupperts, Raymond, Van Pesch, Vincent, Lechner-Scott, Jeannette, Cristiano, Edgardo, Fiol, Marcela, Oreja-Guevara, Celia, Saladino, Maria Laura, Taylor, Bruce V., Simpson, Steve, Lepore, Vito, Grand’Maison, Francois, Duquette, Pierre, Izquierdo, Guillermo, Grammond, Pierre, Amato, Maria Pia
Health systems and sustainability: doctors and consumers differ on threats and solutions
- Robertson, Jane, Walkom, Emily J., Henry, David A.
Managing potential conflict of interest in journal article publication
- O'Brien, Louise, Lakeman, Richard, O'Brien, Anthony
- Robertson, Jane, Walkom, Emily, Moynihan, Ray, Bero, Lisa, Henry, David
Selling sickness: the pharmaceutical industry and disease mongering
- Moynihan, Ray, Heath, Iona, Henry, David
- Dang, Thanh T., Vuong, Quan Van, Schreider, Maria J., Bowyer, Michael C., Van Altena, Ian A., Scarlett, Christopher J.
Ties that bind: multiple relationships between clinical researchers and the pharmaceutical industry
- Henry, David, Doran, Evan, Kerridge, Ian, Hill, Suzanne, McNeill, Paul M., Day, Richard
Who's watching the watchdogs?
- Schwartz, Lisa, Woloshin, Steven, Moynihan, Ray
Are you sure you would like to clear your session, including search history and login status?